pseudouridine has been researched along with Inflammation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ruffell, D | 1 |
Akilli-Öztürk, Ö; Berger, H; Bukur, T; Diken, E; Diken, M; Karikó, K; Kirchhoff, S; Kolb, L; Kranz, LM; Kreiter, S; Krienke, C; Petschenka, J; Sahin, U; Streuber, M; Türeci, Ö; Waisman, A; Yogev, N | 1 |
Ionescu, AA; Nixon, LS; Shale, DJ | 1 |
Bolton, CE; Broekhuizen, R; Ionescu, AA; Nixon, LS; Schols, AM; Shale, DJ; Wouters, EF | 1 |
4 other study(ies) available for pseudouridine and Inflammation
Article | Year |
---|---|
The future in an RNA molecule: from mRNA vaccines to therapeutics - An interview with Drew Weissman.
Topics: Antibodies, Monoclonal; Betacoronavirus; Cancer Vaccines; COVID-19; COVID-19 Vaccines; Dendritic Cells; Drug Industry; Genetic Therapy; Humans; Inflammation; Lymphatic System; mRNA Vaccines; Nanoparticles; Precision Medicine; Pseudouridine; RNA Stability; RNA, Messenger; United States; Vaccines, Synthetic | 2021 |
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.
Topics: Animals; Antigen-Presenting Cells; Autoantigens; Bystander Effect; Encephalomyelitis, Autoimmune, Experimental; Immunosuppression Therapy; Inflammation; Mice; Mice, Inbred C57BL; mRNA Vaccines; Multiple Sclerosis; Pseudouridine; RNA, Messenger; T-Lymphocytes, Regulatory; Vaccines, Synthetic | 2021 |
Cellular proteolysis and systemic inflammation during exacerbation in cystic fibrosis.
Topics: Absorptiometry, Photon; Adult; Anti-Bacterial Agents; Biomarkers; Body Composition; Cystic Fibrosis; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Inflammation; Inflammation Mediators; Lung Diseases; Male; Prospective Studies; Proteins; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudouridine; Sputum | 2004 |
Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD.
Topics: Biomarkers; Body Composition; Body Mass Index; Exercise Test; Female; Forced Expiratory Volume; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Muscle Strength; Muscle, Skeletal; Proteins; Pseudouridine; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha | 2007 |